ERBB2 and cancer: The FEO-CSNPs exhibited a more robust HER2 downregulation in MDA-MB-231 cells (p = 0.046077), aligning with Al-Balushi, Haque [34] and Salehi, Jamali [31], who highlighted the enhanced efficacy of essential oil nano-formulations over their free counterparts in cancer treatment.